Three-dimensional external beam radiotherapy for prostate cancer increases the risk of hip fracture (scientific article)

Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)

Q33559123

Time trends and local variation in primary treatment of localized prostate cancer

Q33710948

Radiation-therapy effects on bone density

Q35179811

Excess mortality following hip fracture: the role of underlying health status

Q37312626

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

Q39490012

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

Q41347991

The crippling consequences of fractures and their impact on quality of life

Q41597014

Duration of androgen suppression in the treatment of prostate cancer

Q43859500

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

Q44070350

Risk factors for fracture following a fall among older people in residential care facilities in Australia

Q44695824

Early failure of acetabular components inserted without cement after previous pelvic irradiation

Q70871002

Randomized study on preoperative radiotherapy in rectal carcinoma. Stockholm Colorectal Cancer Study Group

Q71697481

Total hip replacement in irradiated hips. A retrospective study of 71 cases

Q71824622

Radiation osteitis and insufficiency fractures after pelvic irradiation for gynecologic malignancies

Q72448018

Pelvic insufficiency fractures associated with radiation atrophy: clinical recognition and diagnostic evaluation

Q73131248

Fracture risk following bilateral orchiectomy

Q73247169

Intensity-modulated radiotherapy for a prostate patient with a metal prosthesis

Q77363461

Risk of fracture after androgen deprivation for prostate cancer

Q81264327

Diagnosis and treatment of osteoporosis

Q83316238

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

bone fracture

Q68833

adaptive radiation therapy

Q180507

prostate cancer

Q181257

P304

page(s)

4557-4565

P577

publication date

2011-03-16

P1433

published in

Cancer

Q326041

P1476

title

Three-dimensional external beam radiotherapy for prostate cancer increases the risk of hip fracture

P478

volume

117

Reverse relations

cites work (P2860)

Q48073617	American Cancer Society prostate cancer survivorship care guidelines.
Q98226193	Bone Fracture Incidence After Androgen Deprivation Therapy-Investigational Agents: Results From Cancer Therapy Evaluation Program-Sponsored Early Phase Clinical Trials 2006-2013
Q34615270	Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment
Q36083816	Falls in older adults with cancer: a systematic review of prevalence, injurious falls, and impact on cancer treatment.
Q37037832	High-risk prostate cancer: is androgen deprivation monotherapy still appropriate?
Q50876255	Hip fractures and pain following proton therapy for management of prostate cancer.
Q41284066	Hip-related toxicity after prostate radiotherapy: Treatment related or coincidental?
Q92140145	Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study
Q34268907	Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer
Q36558651	Is Radiation Necessary for Treatment of Non-Hodgkin's Lymphoma of Bone? Clinical Results With Contemporary Therapy
Q47991795	Longitudinal Effects of Single Hindlimb Radiation Therapy on Bone Strength and Morphology at Local and Contralateral Sites
Q89949281	Osteoporosis screening using computed tomography for men with prostate cancer: results of a prospective study
Q36920155	PTH prevents the adverse effects of focal radiation on bone architecture in young rats
Q34651175	Pelvic irradiation does not increase the risk of hip replacement in patients with gynecological cancer. A cohort study based on 8,507 patients
Q36665817	The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancer